R
Ricardo G. Correa
Researcher at Discovery Institute
Publications - 110
Citations - 4671
Ricardo G. Correa is an academic researcher from Discovery Institute. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 35, co-authored 90 publications receiving 3844 citations. Previous affiliations of Ricardo G. Correa include University of Arizona & Ludwig Institute for Cancer Research.
Papers
More filters
Journal ArticleDOI
Dopamine: Functions, Signaling, and Association with Neurological Diseases
Marianne O. Klein,Daniella S. Battagello,Ariel R. Cardoso,David N. Hauser,Jackson C. Bittencourt,Ricardo G. Correa +5 more
TL;DR: The aspects of dopamine as a catecholaminergic neurotransmitter and dopamine signaling pathways elicited through dopamine receptor activation in normal brain function are summarized and the potential involvement of these signaling pathways in evoking the onset and progression of some diseases in the nervous system are described.
Journal ArticleDOI
Shotgun sequencing of the human transcriptome with ORF expressed sequence tags
Emmanuel Dias Neto,Ricardo G. Correa,Sergio Verjovski-Almeida,Marcelo R.S. Briones,Maria Aparecida Nagai,Wilson da Silva,Marco Antônio Zago,Silvana Bordin,Fernando Ferreira Costa,Gustavo H. Goldman,Alex F. Carvalho,Adriana Yamaguti Matsukuma,Gilson S. Baia,David H. Simpson,Adriana Brunstein,Paulo S. L. Oliveira,Philipp Bucher,C. Victor Jongeneel,Michael J. O'Hare,Fernando Augusto Soares,Ricardo R. Brentani,Luis F.L. Reis,Sandro J. de Souza,Andrew J. G. Simpson +23 more
TL;DR: Theoretical considerations predict that amplification of expressed gene transcripts by reverse transcription-PCR using arbitrarily chosen primers will result in the preferential amplification of the central portion of the transcript, and this approach should make a significant contribution to the early identification of important human genes.
Journal ArticleDOI
Carney complex: an update
TL;DR: This report reviews CNC, its clinical features, diagnosis, treatment and molecular etiology, including PRKAR1A mutations and the newest on PRKACA and PRKACB defects especially as they pertain to adrenal tumors and Cushing's syndrome.
Journal ArticleDOI
XIAP mediates NOD signaling via interaction with RIP2
Andreas Krieg,Ricardo G. Correa,Jason B. Garrison,Gaëlle Le Negrate,Kate Welsh,Ziwei Huang,Wolfram T. Knoefel,John C. Reed +7 more
TL;DR: A role for XIAP in regulating innate immune responses by interacting with NOD1 and NOD2 through interaction with RIP2 is suggested, providing evidence that XIAP associates with the NOD signalosome.
Journal ArticleDOI
Roles of NOD1 (NLRC1) and NOD2 (NLRC2) in innate immunity and inflammatory diseases.
TL;DR: Recent experimental findings associating NOD1 and NOD2 with various autoimmune and chronic inflammatory disorders are described, prospects for development of novel therapeutics targeting these NLR family proteins are discussed, and they are discussed.